Filing Details
- Accession Number:
- 0000899243-17-004945
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-22 16:05:19
- Reporting Period:
- 2017-02-21
- Filing Date:
- 2017-02-22
- Accepted Time:
- 2017-02-22 16:05:19
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
31791 | Perkinelmer Inc | PKI | Laboratory Analytical Instruments (3826) | 042052042 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1044005 | P Alexis Michas | 940 Winter Street Waltham MA 02451 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2017-02-21 | 8,308 | $23.36 | 61,623 | No | 4 | M | Direct | |
Common Stock | Disposition | 2017-02-21 | 8,308 | $55.60 | 53,328 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | NQ Stock Option (right to buy) | Disposition | 2017-02-21 | 8,308 | $0.00 | 8,308 | $23.36 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | 2017-05-11 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 500 | Indirect | By spouse IRA |
Footnotes
- Includes shares related to dividends on shares in the Reporting Person's Deferred Compensation Plan account.
- The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $55.595 to $55.630. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price.
- This option became exercisable in three equal annual installments beginning on May 11, 2011, which was the first anniversary of the date on which the option was granted.